These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35186166)

  • 1. Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer.
    Nie L; Zhang C; Song H; Zhao Q; Cheng L; Zhang P; Yang X
    Dis Markers; 2022; 2022():3554100. PubMed ID: 35186166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
    Ni PZ; He JZ; Wu ZY; Ji X; Chen LQ; Xu XE; Liao LD; Wu JY; Li EM; Xu LY
    Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1.
    Liu YP; Pan LL; Kong CC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7335-7344. PubMed ID: 32706072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
    Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
    Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
    Suzuki K; Watanabe A; Araki K; Yokobori T; Harimoto N; Gantumur D; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Gombodorj N; Nishiyama M; Hosouchi Y; Kuwano H; Shirabe K
    Anticancer Res; 2018 Feb; 38(2):939-944. PubMed ID: 29374725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
    Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
    Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
    Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
    Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P; Yokobori T; Altan B; Iijima M; Azuma Y; Onozato R; Yajima T; Watanabe A; Mogi A; Shimizu K; Nagashima T; Ohtaki Y; Obayashi K; Nakazawa S; Bai T; Kawabata-Iwakawa R; Asao T; Kaira K; Nishiyama M; Kuwano H
    Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma.
    He X; Liao Y; Lu W; Xu G; Tong H; Ke J; Wan X
    Tumour Biol; 2016 Jul; 37(7):9951-8. PubMed ID: 26815505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.
    Kang W; Tong JH; Chan AW; Lung RW; Chau SL; Wong QW; Wong N; Yu J; Cheng AS; To KF
    PLoS One; 2012; 7(3):e33919. PubMed ID: 22470493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
    Dos Santos Passaia B; Lima K; Kremer JL; da Conceição BB; de Paula Mariani BM; da Silva JCL; Zerbini MCN; Fragoso MCBV; Machado-Neto JA; Lotfi CFP
    Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of stathmin 1 is a poor prognostic biomarker in non-small cell lung cancer.
    Nie W; Xu MD; Gan L; Huang H; Xiu Q; Li B
    Lab Invest; 2015 Jan; 95(1):56-64. PubMed ID: 25384122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
    Zhu L; Chen Y; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
    Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
    Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration.
    Chen Y; Zhang Q; Ding C; Zhang X; Qiu X; Zhang Z
    Int J Oncol; 2017 Jan; 50(1):31-40. PubMed ID: 27878293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Obayashi S; Horiguchi J; Higuchi T; Katayama A; Handa T; Altan B; Bai T; Bao P; Bao H; Yokobori T; Nishiyama M; Oyama T; Kuwano H
    Int J Oncol; 2017 Sep; 51(3):781-790. PubMed ID: 28766688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
    Li J; Hu GH; Kong FJ; Wu KM; He B; Song K; Sun WJ
    Neoplasma; 2014; 61(2):144-52. PubMed ID: 24299310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA ZNF609 promotes angiogenesis in nasopharyngeal carcinoma by regulating miR-145/STMN1 axis.
    Wang J; Lin Y; Jiang DH; Yang X; He XG
    Kaohsiung J Med Sci; 2021 Aug; 37(8):686-698. PubMed ID: 33943007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.